Please ensure Javascript is enabled for purposes of website accessibility

Why BioMed Realty Trust Inc is Moving Higher Today

By Brian Feroldi - Sep 23, 2015 at 11:36AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Reports that the company is looking for a buyout caused its stock to spike.

What: Shares of BioMed Realty Trust (NYSE: BMR), a real estate investment trust, or REIT, that specializes in providing properties to the life science industry, were soaring 13% higher today as news broke that the company is looking to sell itself.

So what: Bloomberg is reporting that that the San Diego-based BioMed is currently working with Morgan Stanley to find a company to that would be interested in acquiring the REIT. According to people familiar with the discussions, the company has already attracted the attention of a number of firms, including private equity giant Blackstone Group LP.

Now what: Whenever news like this breaks, it's no surprise to see investors get excited and rush in to bid up the stock -- but the company itself has yet to issue a press release on the matter, so investors should remember that there is no guarantee that a deal will ever be announced, let alone completed.

Investors in BioMed should be looking to today's stock pop with glee, as the company's stock has been a loser to the market since going public more than a decade ago, even after factoring in reinvestment of the company's juicy dividend, which now stands at over 5%.

BMR Total Return Price Chart

While a short term pop is always fun, if a deal is never formerly announced then it is likely that the stock will fall in response. Thus, anyone investing in BioMed's stock today should be investing on the merits of the company itself, and not merely on the chance of a higher stock price from a buyout. 

While BioMed's business model is certainly interesting, the stock's performance has been uninspiring since going public more than a decade ago -- so I for one will be watching this story play out from the sidelines.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/20/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.